Yang Di, Krois Charles R, Huang Priscilla, Wang Jinshan, Min Jin, Yoo Hong Sik, Deng Yinghua, Napoli Joseph L
Graduate Program in Metabolic Biology, Nutritional Sciences and Toxicology, University of California, Berkeley, California, United States of America.
PLoS One. 2017 Nov 2;12(11):e0187669. doi: 10.1371/journal.pone.0187669. eCollection 2017.
All-trans-retinoic acid (RA) inhibits adipogenesis in established preadipocyte cell lines. Dosing pharmacological amounts of RA reduces weight gain in mice fed a high-fat diet, i.e. counteracts diet-induced obesity (DIO). The aldehyde dehydrogenase Raldh1 (Aldh1a1) functions as one of three enzymes that converts the retinol metabolite retinal into RA, and one of many proteins that contribute to RA homeostasis. Female Raldh1-ablated mice resist DIO. This phenotype contrasts with ablations of other enzymes and binding-proteins that maintain RA homeostasis, which gain adiposity. The phenotype observed prompted the conclusion that loss of Raldh1 causes an increase in adipose tissue retinal, and therefore, retinal functions independently of RA to prevent DIO. A second deduction proposed that low nM concentrations of RA stimulate adipogenesis, in contrast to higher concentrations. Using peer-reviewed LC/MS/MS assays developed and validated for quantifying tissue RA and retinal, we show that endogenous retinal and RA concentrations in adipose tissues from Raldh1-null mice do not correlate with the phenotype. Moreover, male Raldh1-null mice resist weight gain regardless of dietary fat content. Resistance to weight gain occurs during adolescence in both sexes. We show that RA concentrations as low as 1 nM, i.e. in the sub-physiological range, impair adipogenesis of embryonic fibroblasts from wild-type mice. Embryonic fibroblasts from Raldh1-null mice resist differentiating into adipocytes, but retain ability to generate RA. These fibroblasts remain sensitive to an RA receptor pan-agonist, and are not affected by an RA receptor pan-antagonist. Thus, the data do not support the hypothesis that retinal itself represses weight gain and adipogenesis independently of RA. Instead, the data indicate that Raldh1 functions as a retinal and atRA-independent promoter of adiposity during adolescence, and enhances adiposity through pre-adipocyte cell autonomous actions.
全反式维甲酸(RA)可抑制已建立的前脂肪细胞系中的脂肪生成。给予药理剂量的RA可减少高脂饮食喂养小鼠的体重增加,即抵消饮食诱导的肥胖(DIO)。醛脱氢酶Raldh1(Aldh1a1)作为将视黄醇代谢产物视黄醛转化为RA的三种酶之一,也是有助于RA稳态的众多蛋白质之一。雌性Raldh1基因敲除小鼠可抵抗DIO。该表型与维持RA稳态的其他酶和结合蛋白的敲除形成对比,后者会导致肥胖。观察到的表型促使人们得出结论,即Raldh1的缺失会导致脂肪组织中视黄醛增加,因此,视黄醛独立于RA发挥作用以预防DIO。另一个推论是,与较高浓度相比,低纳摩尔浓度的RA会刺激脂肪生成。使用经过开发和验证的用于定量组织RA和视黄醛的同行评审的液相色谱/串联质谱分析方法,我们发现Raldh1基因敲除小鼠脂肪组织中的内源性视黄醛和RA浓度与该表型无关。此外,无论饮食脂肪含量如何,雄性Raldh1基因敲除小鼠均能抵抗体重增加。两性在青春期均会出现体重增加抵抗。我们发现,低至1纳摩尔的RA浓度,即在亚生理范围内,会损害野生型小鼠胚胎成纤维细胞的脂肪生成。Raldh1基因敲除小鼠的胚胎成纤维细胞可抵抗分化为脂肪细胞,但仍保留产生RA的能力。这些成纤维细胞对视黄酸受体泛激动剂仍敏感,且不受视黄酸受体泛拮抗剂的影响。因此,数据不支持视黄醛本身独立于RA抑制体重增加和脂肪生成的假说。相反,数据表明,Raldh1在青春期作为脂肪生成的视黄醛和全反式维甲酸非依赖性促进因子发挥作用,并通过前脂肪细胞自主作用增强肥胖。